Becton Dickinson, one of the world’s largest medical technology companies, said in a statement Tuesday it has entered into a definitive agreement to sell its surgical instrumentation platform to Steris, an Ohio-based medical device firm specializing in infection prevention.
The sale includes BD’s V. Mueller, Snowden-Pencer and Genesis brands as well as three manufacturing facilities in St. Louis, Cleveland, and Tuttlingen, Germany. Some 360 employees will transfer to Steris when the deal closes by the end of September.
BD’s surgical instrumentation platform is part of the company’s interventional business segment.
In a statement, New Jersey-based BD said selling the platform “advances the ‘Simplify’ pillar” of the firm’s strategy to slim its product portfolio and manufacturing network.
The transaction is significant for Steris, which employs 17,000 people worldwide. The company had global sales of $4.96 billion and a net loss of $27.9 million in its most recent fiscal year.
Needham analysts led by Mike Matson applauded the transaction. READ MORE
By Peter Green
Source: medtechdive.com
The United Arab Emirates (UAE) Ministry of Health and Prevention (MoHAP) has established a partnership with Novo Nordisk Pharma Gulf focusing on the creation of a national scientific guide for obesity management and weight control. The collaboration also aims to enhance public awareness of cardiovascular diseases and their complications.
Pharma giant Eli Lilly is teaming up with Haya Therapeutics in a $1bn deal to find multiple regulatory-genome-derived RNA-based drug targets, as it eyes up new targets in obesity. Under the deal, the companies will use Haya’s proprietary regulatory genome discovery platform to identify and validate long non-coding RNA (lncRNA) targets for developing potential treatments for obesity and related metabolic disorders.
The sale includes custom formulation and contract manufacturing capabilities for the nutrition market from the production facilities in New Jersey and Utah in the United States, and Tamaulipas, Mexico. Financial terms of the transaction were not disclosed.
